SG Americas Securities
DGX icon

SG Americas Securities’s Quest Diagnostics DGX Stock Holding History

SG Americas Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-102,300
Closed -$2.28M – 3718
2020
Q1 		$2.28M Buy
+102,300
New +$10.6M 0.02% 728

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

SG Americas Securities's DGX Position: Q2 2026 in Review

SG Americas Securities reduced its Quest Diagnostics (DGX) stake by 25% in Q2 2026, selling an estimated $10.7M and leaving 162,837 shares worth $34.5M. The position accounts for 0.02% of the portfolio, ranked #440.

SG Americas Securities first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.6M in Q1 2026. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • SG Americas Securities held 162,837 shares of Quest Diagnostics worth $34.5M as of Q2 2026.
  • SG Americas Securities sold 54,449 Quest Diagnostics shares in Q2 2026, an estimated $10.7M.
  • Quest Diagnostics made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #440 holding.
  • SG Americas Securities first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Quest Diagnostics position peaked at $42.6M in Q1 2026.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.